Status:
RECRUITING
Evaluation of Clinical Progression, Prognostic Factors, and Quality of Life in Patients with Age-related Macular Degeneration.
Lead Sponsor:
University of Udine
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
50-120 years
Brief Summary
The VERA-AMD study is a prospective, observational study designed to evaluate clinical progression, prognostic factors, and quality of life in patients with age-related macular degeneration (AMD). The...
Detailed Description
The VERA-AMD study is a prospective, non-interventional, observational study investigating the clinical course, prognostic factors, and quality of life in patients with age-related macular degeneratio...
Eligibility Criteria
Inclusion
- age ≥ 50 years.
- confirmed diagnosis of AMD in at least one eye.
- follow-up scheduled according to standard clinical practice.
Exclusion
- presence of other significant ocular conditions that could affect visual acuity.
- systemic conditions that make the patient unsuitable for long-term follow-up.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2029
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06899360
Start Date
October 1 2024
End Date
October 1 2029
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology
Udine, UD, Italy, 33100